Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001770252-23-000004
Filing Date
2023-03-28
Accepted
2023-03-28 17:23:44
Documents
1
Period of Report
2023-03-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_168003861168211.html 4  
1 FORM 4 wf-form4_168003861168211.xml 4 3284
  Complete submission text file 0001770252-23-000004.txt   4604
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address
Lambert Nicole (Reporting) CIK: 0001770252 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 23770742